Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vasodilator therapy.

F J Sutton

    The American Journal of Medicine
    |February 28, 1986
    PubMed
    Summary

    Vasodilator therapy, including nitrates and captopril, can improve symptoms of congestive heart failure. However, reduced mortality rates have not been proven, and predicting patient response remains challenging.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Predictors of psychosocial adjustment in patients with implantable cardioverter defibrillators.

    Pacing and clinical electrophysiology : PACE·1997
    Same author

    Modified technique for dual chamber pacemaker insertion.

    Surgery, gynecology & obstetrics·1993
    Same author

    Sudden death associated with alcohol consumption.

    Pacing and clinical electrophysiology : PACE·1988
    Same author

    Outpatient dobutamine and dopamine infusions in the management of chronic heart failure: clinical experience in 21 patients.

    American heart journal·1987
    Same author

    Insidious onset of fatigue, dyspnea, and leg edema.

    Archives of internal medicine·1985
    Same author

    Pericardial defect mimicking a left atrial mass.

    The American journal of cardiology·1985

    Area of Science:

    • Cardiology
    • Pharmacology

    Background:

    • Congestive heart failure (CHF) management often requires advanced therapies when initial treatments are insufficient.
    • Vasodilators offer arteriolar or venous dilatation to address persistent CHF symptoms.

    Purpose of the Study:

    • To evaluate the efficacy of vasodilator therapy in patients with persistent congestive heart failure symptoms.
    • To assess the impact of vasodilators on mortality rates in CHF.
    • To explore the predictability of clinical response to vasodilator treatment.

    Main Methods:

    • Review of existing clinical data on vasodilator use in congestive heart failure.
    • Analysis of symptom improvement and mortality data associated with specific vasodilators like nitrates and captopril.

    Main Results:

    • Nitrates and captopril demonstrate consistent symptomatic improvement in CHF patients.
    • No definitive reduction in mortality rates has been established with vasodilator therapy for CHF.
    • Clinical response to vasodilator therapy in CHF is difficult to predict.

    Conclusions:

    • Vasodilators are valuable for symptom management in refractory congestive heart failure.
    • Current evidence does not support a mortality benefit from vasodilator therapy in CHF.
    • Further research is needed to improve the prediction of treatment response.

    Related Experiment Videos